U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C53H102N2O20P2
Molecular Weight 1149.3259
Optical Activity UNSPECIFIED
Defined Stereocenters 12 / 12
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DEFOSLIMOD

SMILES

CCCCCCCCCCC[C@@H](O)CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](O)[C@H]2NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)O[C@H]1COP(O)(O)=O

InChI

InChIKey=UUVVKHSZRKZOGM-CUECXTGJSA-N
InChI=1S/C53H102N2O20P2/c1-4-7-10-13-16-19-22-25-28-31-39(57)34-44(58)54-47-42(38-71-76(64,65)66)73-43(49(61)50(47)62)37-70-53-48(51(63)52(41(36-56)74-53)75-77(67,68)69)55-45(59)35-40(32-29-26-23-20-17-14-11-8-5-2)72-46(60)33-30-27-24-21-18-15-12-9-6-3/h39-43,47-53,56-57,61-63H,4-38H2,1-3H3,(H,54,58)(H,55,59)(H2,64,65,66)(H2,67,68,69)/t39-,40-,41-,42+,43-,47+,48-,49-,50-,51-,52-,53-/m1/s1

HIDE SMILES / InChI

Molecular Formula C53H102N2O20P2
Molecular Weight 1149.3259
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 12 / 12
E/Z Centers 0
Optical Activity UNSPECIFIED

Defoslimod is an analog of lipopolysaccharide endotoxin-derived lipid A obtained from E. coli, developed as an immunomodulatory adjuvant and an immunotherapeutic agent for the treatment of cancer. Defoslimod acts as an agonist of Toll-like receptor (TLR) 2/4. In a phase 1 clinical study in patients with solid tumors, conducted in 2007, defoslimod was administered as an intravenous infusion. The therapy was well tolerated at biologically active concentrations, with 3 patients of 17 exhibited disease stabilization with a mean duration of 4 months. No further development of the drug was reported.

Approval Year

Substance Class Chemical
Created
by admin
on Fri Dec 15 19:37:50 UTC 2023
Edited
by admin
on Fri Dec 15 19:37:50 UTC 2023
Record UNII
HC3530GGGG
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DEFOSLIMOD
INN  
INN  
Official Name English
2-DEOXY-6-O-(2-DEOXY-2-((R)-3-HYDROXYTETRADECANAMIDO)-.BETA.-D-GLUCOPYRANOSYL)-2-((R)-3-HYDROXYTETRADECANAMIDO)-.ALPHA.-D-GLUCOPYRANOSE 1,6'-BIS(DIHYDROGEN PHOSPHATE) 2'(3)-LAURATE
Common Name English
OM-174
Code English
OM174
Code English
.ALPHA.-D-GLUCOPYRANOSE, 2-DEOXY-6-O-(2-DEOXY-2-((1-OXO-3-((1-OXODODECYL)OXY)TETRADECYL)AMINO)-4-O-PHOSPHONO-.BETA.-D-GLUCOPYRANOSYL)-2-((3-HYDROXY-1-OXOTETRADECYL)AMINO)-, 1-(DIHYDROGEN PHOSPHATE), (2(R),6(R))-
Common Name English
defoslimod [INN]
Common Name English
.ALPHA.-D-GLUCOPYRANOSE, 2-DEOXY-6-O-(2-DEOXY-2-(((3R)-1-OXO-3-((1-OXODODECYL)OXY)TETRADECYL)AMINO)-4-O-PHOSPHONO-.BETA.-D-GLUCOPYRANOSYL)-2-(((3R)-3-HYDROXY-1-OXOTETRADECYL)AMINO)-, 1-(DIHYDROGEN PHOSPHATE)
Common Name English
Code System Code Type Description
NCI_THESAURUS
C169880
Created by admin on Fri Dec 15 19:37:50 UTC 2023 , Edited by admin on Fri Dec 15 19:37:50 UTC 2023
PRIMARY
FDA UNII
HC3530GGGG
Created by admin on Fri Dec 15 19:37:50 UTC 2023 , Edited by admin on Fri Dec 15 19:37:50 UTC 2023
PRIMARY
MESH
C400105
Created by admin on Fri Dec 15 19:37:50 UTC 2023 , Edited by admin on Fri Dec 15 19:37:50 UTC 2023
PRIMARY
INN
7734
Created by admin on Fri Dec 15 19:37:50 UTC 2023 , Edited by admin on Fri Dec 15 19:37:50 UTC 2023
PRIMARY
CAS
171092-39-0
Created by admin on Fri Dec 15 19:37:50 UTC 2023 , Edited by admin on Fri Dec 15 19:37:50 UTC 2023
PRIMARY
ChEMBL
CHEMBL2105854
Created by admin on Fri Dec 15 19:37:50 UTC 2023 , Edited by admin on Fri Dec 15 19:37:50 UTC 2023
PRIMARY
PUBCHEM
56841121
Created by admin on Fri Dec 15 19:37:50 UTC 2023 , Edited by admin on Fri Dec 15 19:37:50 UTC 2023
PRIMARY
SMS_ID
300000042682
Created by admin on Fri Dec 15 19:37:50 UTC 2023 , Edited by admin on Fri Dec 15 19:37:50 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> AGONIST
TARGET -> AGONIST
Related Record Type Details
ACTIVE MOIETY